C
25.38
0.53 (2.13%)
| Penutupan Terdahulu | 24.85 |
| Buka | 25.08 |
| Jumlah Dagangan | 875,340 |
| Purata Dagangan (3B) | 1,579,604 |
| Modal Pasaran | 3,751,669,760 |
| Harga / Jualan (P/S) | 197.93 |
| Harga / Buku (P/B) | 8.96 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Nov 2025 |
| Margin Operasi (TTM) | -205.18% |
| EPS Cair (TTM) | -1.88 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 30.55% |
| Nisbah Semasa (MRQ) | 14.37 |
| Aliran Tunai Operasi (OCF TTM) | -162.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -106.95 M |
| Pulangan Atas Aset (ROA TTM) | -28.58% |
| Pulangan Atas Ekuiti (ROE TTM) | -74.44% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Centessa Pharmaceuticals plc | Menurun | Menaik |
AISkor Stockmoo
1.8
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 1.75 |
|
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 0.50% |
| % Dimiliki oleh Institusi | 94.39% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Index Venture Life Associates Vi Ltd | 30 Sep 2025 | 9,961,789 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 62.00 (Oppenheimer, 144.29%) | Beli |
| Median | 40.00 (57.60%) | |
| Rendah | 30.00 (Chardan Capital, 18.20%) | Beli |
| Purata | 42.40 (67.06%) | |
| Jumlah | 5 Beli | |
| Harga Purata @ Panggilan | 26.57 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wolfe Research | 24 Feb 2026 | 40.00 (57.60%) | Beli | 26.23 |
| Truist Securities | 29 Jan 2026 | 38.00 (49.72%) | Beli | 24.89 |
| 08 Jan 2026 | 33.00 (30.02%) | Beli | 22.05 | |
| Chardan Capital | 02 Jan 2026 | 30.00 (18.20%) | Beli | 23.69 |
| Oppenheimer | 10 Dec 2025 | 62.00 (144.29%) | Beli | 29.57 |
| B. Riley Securities | 01 Dec 2025 | 42.00 (65.48%) | Beli | 28.47 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |